Cargando…
Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study
Autores principales: | Anagnostis, Panagiotis, Selalmatzidou, Despina, Sapranidis, Michalis, Panagiotou, Athanasios, Polyzos, Stergios A., Slavakis, Aristidis, Kita, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263188/ https://www.ncbi.nlm.nih.gov/pubmed/22276270 http://dx.doi.org/10.4103/2230-8210.91214 |
Ejemplares similares
-
Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
por: Anagnostis, Panagiotis, et al.
Publicado: (2014) -
The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015) -
Efficacy and Tolerability of the Association of Sibutramine and
Orlistat for Six Months in Overweight and Obese Patients
por: Halpern, Alfredo, et al.
Publicado: (2010) -
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
por: Vickers, Steven P, et al.
Publicado: (2014) -
Coexistence of a large functioning parathyroid cyst with papillary thyroid carcinoma: A case report and review of the literature
por: Anagnostis, Panagiotis, et al.
Publicado: (2018)